World's Best Scientists 2026 revealed!
John Kjekshus

John Kjekshus

D-Index & Metrics

Medicine

D-Index
108
Citations
96237
World Ranking
5853
National Ranking
19

Overview

John Kjekshus is affiliated with the University of Oslo in Norway and has contributed to the field of medicine with a focus on several subfields including surgery, endocrinology, diabetes and metabolism, genetics, emergency medicine, and economics and econometrics.

Their research spans key topics such as:

  • Lipoproteins and Cardiovascular Health
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • HIV-related health complications and treatments
  • Health Systems, Economic Evaluations, Quality of Life
  • Genomics and Rare Diseases
  • Genetics and Neurodevelopmental Disorders
  • Cardiomyopathy and Myosin Studies

Frequent coauthors include Christina Reith, Colin Baigent, Lisa Blackwell, Jonathan Emberson, and Enti Spata.

The publication venues where they have contributed most often include:

  • Tidsskrift for Den norske legeforening
  • The Lancet
  • The Lancet Diabetes & Endocrinology
  • JAMA Cardiology

Recent papers authored or coauthored by John Kjekshus cover diverse aspects of medicine and cardiovascular health. These include:

  • "Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials" (2022, The Lancet)
  • "Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis" (2024, The Lancet Diabetes & Endocrinology)
  • "Assessing the Role of Rare Genetic Variation in Patients With Heart Failure" (2020, JAMA Cardiology)
  • "Halfdan Ihlen" (2022, Tidsskrift for Den norske legeforening)
  • "Kolbjørn Forfang" (2022, Tidsskrift for Den norske legeforening)

Best Publications

  • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

    A.G. Olsson;J McMurray;G Thorgeirsson;C Spaulding

  • Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

    Elliott Antman;Jean-Pierre Bassand;Werner Klein;Magnus Ohman

  • Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)

    Karl Swedberg;John Kjekshus

  • Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

    A. Hjalmarson;S. Goldstein;B. Fagerberg;H. Wedel

  • ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)☆☆☆

    Alberico L. Catapano;Zeljko Reiner;Guy De Backer;Ian Graham

  • Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

    Naveed Sattar;David Preiss;Heather M Murray;Paul Welsh

  • Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

    Pyŏrälä K;Pedersen Tr;Kjekshus J;Faergeman O

  • ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.

    R Collins;R Peto;M Flather;S Parish

  • Rosuvastatin in Older Patients with Systolic Heart Failure

    John Kjekshus;Eduard Apetrei;Vivencio Barrios;Michael Böhm

  • Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)

    A. Hjalmarson;S. Goldstein;B. Fagerberg;H. Wedel

  • Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions

    Peter R. Maroko;John K. Kjekshus;Burton E. Sobel;Tan Watanabe

  • Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial

    Kenneth Dickstein;John Kjekshus

  • Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.

    K Swedberg;P Eneroth;J Kjekshus;L Wilhelmsen

  • Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

    Karl Swedberg;Peter Held;John Kjekshus;Knut Rasmussen

  • ESC/EAS Guidelines for the management of dyslipidaemias

    Alberico L. Catapano;Željko Reiner;Guy De Backer;Ian Graham

  • Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)

    Terje R. Pedersen;Anders G. Olsson;Ole Færgeman;John Kjekshus

  • HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment

    R. Haynes;L. Jiang;J. C. Hopewell;J Li

  • Indications for ACE inhibitors in the early treatment of acute myocardial infarction - Systematic overview of individual data from 100,000 patients in randomized trials

    M G Franzosi;E Santoro;G Zuanetti;C Baigent

  • The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

    Cynthia J Girman;Thomas Rhodes;Michele Mercuri;Kalevi Pyörälä

  • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

    Terje R Pedersen

Frequent Co-Authors

Lars Gullestad
Lars Gullestad Oslo University Hospital
John J.V. McMurray
John J.V. McMurray University of Glasgow
Thor Ueland
Thor Ueland University of Oslo
Pål Aukrust
Pål Aukrust Oslo University Hospital
Kenneth Dickstein
Kenneth Dickstein University of Bergen
Hans Wedel
Hans Wedel University of Gothenburg
John G.F. Cleland
John G.F. Cleland University of Glasgow
Terje R. Pedersen
Terje R. Pedersen Oslo University Hospital
Dirk J. van Veldhuisen
Dirk J. van Veldhuisen University Medical Center Groningen
Stig S. Frøland
Stig S. Frøland University of Oslo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine, there are several related online programs that can help accelerate your journey or broaden your opportunities. For those wishing to enter healthcare quickly, fast track LPN programs allow you to become a Licensed Practical Nurse in less time than traditional routes. This can be a great starting point for hands-on clinical experience.

If mental health interests you, the demand for nurse practitioners is growing rapidly. Earning your credentials via online PMHNP programs can lead to specialized roles in psychiatric care, all while studying remotely.

Prefer to work on the administrative side of healthcare? A healthcare administration degree online provides flexible training in management, policy, and leadership. For advanced positions, consider one of the most affordable online MHA programs to gain a master’s-level qualification without breaking the bank.

Best Scientists Citing John Kjekshus

Trending Scientists

Recently Published Articles